Ascendis Health Limited provides earnings guidance for the full year ended June 2023. For the year, company expects earnings per share will be between 11.2 cents and 13.7 cents, representing a decrease of between 88.1% and 85.4% compared to the restated earnings per share from total operations of 93.6 cents reported for the prior corresponding period; and headline loss per share will be between 35.7 cents and 43.6 cents, representing an improvement of between 55.8% and 46.0% compared to the restated headline loss per share from total operations of 80.8 cents reported for the prior corresponding period.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8 ZAR | 0.00% | 0.00% | +2.56% |
Mar. 29 | Ascendis Health Seeks Acquisitions | CI |
Mar. 28 | Ascendis Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.56% | 26.6M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ASC Stock
- News Ascendis Health Limited
- Ascendis Health Limited Provides Earnings Guidance for the Year Ended 30 June 2023